logo

For the Inventor, By the Inventor

Indianapolis, IN, United States of America

James Joseph Droste

This inventor holds 33 USPTO granted patents, primarily in Pharmaceutical Compositions. Top assignees: Eli Lilly and Company, Athena Neurosciences, Inc., Elan Pharmaceuticals, Inc.. Active years: 1994-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James Joseph Droste. Retrieved from https://idiyas.com/inventor/james-joseph-droste

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 33

% Patents Active = 57.6

Average Co-Inventor Count = 7.3

ph-index = 10

Forward Citations = 255(Granted Patents)


Location History:

  • Indianapolis,, IN (US) (1996)
  • Indianapolis, IN (US) (1994 - 2009)

Company Filing History:

goldMedal18 out of 4,514 
 
Eli Lilly and Company
 patents
silverMedal4 out of 35 
 
Athena Neurosciences, Inc.
 patents
bronzeMedal1 out of 202 
 
Elan Pharmaceuticals, Inc.
 patents
4. 1 out of 10 
 
Eli Lilly Company
 patents
5. 14 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 1994-2009

Loading Chart...
Areas of Expertise:
Pharmaceutical Compositions
β-Amyloid Inhibition
Heterocyclic Compounds
Cycloalkyl
Lactam
Lactone
Tetrahydro-Beta-Carbolines
Indole-Ethanamines
Synthetic Intermediates
Tetrahydro-Pyrido-Indole
Tricyclic Steroid Hormones
Compounds
33 patents (USPTO):Explore Patents
1. 7482344 - Tricyclic steroid hormone nuclear receptor modulators (2009-01-27),
2. 7390801 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds (2008-06-24),
3. 6951854 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds (2005-10-04),
4. 6888022 - Methods and compounds for inhibiting β-amyloid peptide release and/or its synthesis (2005-05-03),
5. 6861558 - Methods and compounds for inhibiting β-amyloid peptide release and/or its synthesis (2005-03-01),
6. 6849650 - Heterocyclic compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds (2005-02-01),
7. 6683075 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use (2004-01-27),
8. 6667305 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds (2003-12-23),
9. 6653303 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds (2003-11-25),
10. 6635632 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds (2003-10-21),
11. 6632811 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds (2003-10-14),
12. 6579867 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds (2003-06-17),
13. 6559141 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds (2003-05-06),
14. 6544978 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds (2003-04-08),
15. 6541466 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds (2003-04-01),

Title: The Innovative Journey of James Joseph Droste

Introduction: James Joseph Droste, a pioneering inventor based in Indianapolis, IN (US), has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: James Joseph Droste's latest patents include cutting-edge technologies in the fields of artificial intelligence, renewable energy, and medical devices, showcasing his versatility and forward-thinking approach to innovation.

Career Highlights: With over two decades of experience in the industry, James Joseph Droste has established himself as a leading figure in the world of inventors. His career highlights include the development of a revolutionary smart home system that has transformed the way people interact with their living spaces.

Collaborations: Throughout his career, James Joseph Droste has collaborated with top research institutions, leading companies, and innovative startups to bring his inventions to life. His ability to work across disciplines and industries has led to the creation of groundbreaking technologies that have had a lasting impact on society.

Conclusion: James Joseph Droste's passion for innovation, coupled with his dedication to pushing the boundaries of what is possible, has solidified his reputation as a visionary inventor. His relentless pursuit of excellence continues to inspire the next generation of inventors to think big and create a better future for all.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…